(Q46985556)

27 December 2017

title

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury (English)

1 reference

27 December 2017

0 references

0 references

1 reference

4

Raphael Mechoulam

1 reference

27 December 2017

3

Ruth Gallily

1 reference

27 December 2017

author name string

Ronen Durst

1

1 reference

27 December 2017

Haim Danenberg

2

1 reference

27 December 2017

Keren Meir

5

1 reference

27 December 2017

Etty Grad

6

1 reference

27 December 2017

Ronen Beeri

7

1 reference

27 December 2017

Thea Pugatsch

8

1 reference

27 December 2017

Elizabet Tarsish

9

1 reference

27 December 2017

Chaim Lotan

10

1 reference

27 December 2017

publication date

21 September 2007

1 reference

27 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

27 December 2017

volume

293

1 reference

27 December 2017

issue

6

1 reference

27 December 2017

page(s)

H3602-7

1 reference

27 December 2017

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Isolation and structure of .DELTA.+- tetrahydrocannabinol and other neutral cannabinoids from hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Meta-analysis of corticosteroid treatment in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

A3 adenosine receptor-mediated protection of the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Targeting C-reactive protein for the treatment of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Cardioprotection with adenosine A2 receptor activation at reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2007

10.1152/AJPHEART.00098.2007

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017